Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
January 09, 2019 16:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
January 09, 2019 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J. and RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics...
Cancer Genetics Terminates Proposed Merger with NovellusDx
December 17, 2018 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
November 19, 2018 16:16 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics Appoints Glenn Miles as Chief Financial Officer
November 14, 2018 16:01 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
October 18, 2018 09:05 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics Issues Letter to Shareholders
October 16, 2018 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
October 08, 2018 07:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics Enters Supply Agreement with Agilent Technologies
September 25, 2018 16:01 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
September 20, 2018 08:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...